cyclohexanol has been researched along with Anankastic Personality in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 19 (70.37) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherian, AV; Math, SB; Narayanaswamy, JC; Reddy, YC; Viswanath, B | 1 |
| Vitiello, B | 1 |
| Denys, D; van Megen, H; Westenberg, H | 1 |
| Sevincok, L; Uygur, B | 1 |
| Aguglia, E; Albert, U; Bogetto, F; Maina, G | 1 |
| Denys, D; Heijnen, CJ; Kavelaars, A; Westenberg, H | 1 |
| Denys, DA; Glas, G; Tenney, NH; van Megen, HJ; Westenberg, HG | 1 |
| Allen, A; Birnbaum, M; Friedberg, J; Hollander, E; Koran, LM; Wasserman, S | 1 |
| Marazziti, D | 1 |
| Burger, H; de Geus, F; Denys, D; van Megen, H; Westenberg, H | 1 |
| Denys, D; van der Wee, N; van Megen, HJ; Westenberg, HG | 2 |
| Cates, ME; Phelps, NJ | 1 |
| Denys, DA; Tenneij, NH; van Megen, HJ; Westenberg, HG | 1 |
| Denys, D; Fluitman, S; Heijnen, C; Kavelaars, A; Westenberg, HG | 1 |
| Allen, A; Dell'Osso, B; Hollander, E; Nestadt, G | 1 |
| Cottraux, J | 1 |
| Deforce, D; Denys, D; Van Nieuwerburgh, F; Westenberg, HG | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Gormly, LJ; Pleak, RR | 1 |
| Ananth, J; Burgoyne, K; Smith, M; Swartz, R | 1 |
| Grossman, R; Hollander, E | 1 |
| Neziroglu, FA; Yaryura-Tobias, JA | 1 |
| Jenike, MA; O'Sullivan, RL; Rauch, SL | 1 |
| Donnelly, NJ; Khouzam, HR | 1 |
| Ninan, PT | 1 |
| Fawcett, J; Guy, C; Zajecka, JM | 1 |
4 review(s) available for cyclohexanol and Anankastic Personality
| Article | Year |
|---|---|
The role of venlafaxine in the treatment of obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Cyclohexanols; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
Topics: Adrenergic Uptake Inhibitors; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Double-Blind Method; Drug Resistance; Duloxetine Hydrochloride; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
[Psychotherapies: what is the impact on the cortical and subcortical levels?].
Topics: Brain; Cyclohexanols; Depression; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Use of venlafaxine in other psychiatric disorders.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride | 2000 |
13 trial(s) available for cyclohexanol and Anankastic Personality
| Article | Year |
|---|---|
Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine open-label treatment of patients with obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride | 2002 |
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
Topics: Acute Disease; Adult; Ambulatory Care; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Behavior; Venlafaxine Hydrochloride | 2003 |
Venlafaxine in treatment-resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Child; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.
Topics: Adolescent; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2003 |
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Patient Dropouts; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.
Topics: Adult; Ambulatory Care; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.
Topics: Adult; Cyclohexanols; Cytokines; Double-Blind Method; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2006 |
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine in obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride | 1996 |
10 other study(ies) available for cyclohexanol and Anankastic Personality
| Article | Year |
|---|---|
Venlafaxine in treatment resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Cyclohexanols; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
Topics: Cyclohexanols; Female; Humans; Lymphocyte Activation; Middle Aged; Obsessive-Compulsive Disorder; Recurrence; Selective Serotonin Reuptake Inhibitors; Sinusitis; T-Lymphocytes; Venlafaxine Hydrochloride | 2002 |
Venlafaxine treatment of obsessive-compulsive disorder: case reports.
Topics: Adult; Cyclohexanols; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Effects of venlafaxine treatment for ADHD in a child.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Cyclohexanols; Female; Humans; Hypertension; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Venlafaxine for treatment of obsessive-compulsive disorder.
Topics: Adult; Cyclohexanols; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Treatment of obsessive-compulsive disorder with venlafaxine.
Topics: Adult; Cyclohexanols; Drug Administration Schedule; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Remission of traumatic brain injury-induced compulsions during venlafaxine treatment.
Topics: Antidepressive Agents, Second-Generation; Craniotomy; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Head Injuries, Closed; Hematoma, Epidural, Cranial; Humans; Male; Middle Aged; Neurocognitive Disorders; Obsessive-Compulsive Disorder; Postoperative Complications; Recurrence; Venlafaxine Hydrochloride | 1998 |
Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drugs, Investigational; Humans; Male; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride | 1990 |